| Literature DB >> 35489013 |
Linda Fenske1,2, Irene Noll3, Jochen Blom4, Christa Ewers5, Torsten Semmler6, Ahmad Fawzy7,8, Tobias Eisenberg7,5.
Abstract
Bovine mastitis causes enormous economic losses in the dairy industry with Streptococcus uberis as one of the most common bacterial pathogens causing clinical and subclinical variations. In most cases mastitis can be cured by intramammary administration of antimicrobial agents. However, the severity of the clinical manifestations can vary greatly from mild to severe symtoms. In this study, a comparative genomic analysis of 24 S. uberis isolates from three dairy farms in Germany, affected by different courses of infection was conducted. While there were sporadic mild infections in farm A and B, a large number of infections were observed within a very short period of time in farm C. The comparison of virulence genes, antimicrobial resistance genes and prophage regions revealed no features that might be responsible for this severe course. However, almost all isolates from farm C showed the same, novel MLST profile (ST1373), thus a clonal outbreak cannot be excluded, whereby the actual reason for the particular virulence remains unknown. This study demonstrates the importance of extensive metagenomic studies, including the host genomes and the environment, to gain further evidence on the pathogenicity of S. uberis.Entities:
Keywords: Bovine mastitis; Comparative genomics; Multilocus sequence typing; Prophage regions; Resistance; Streptococcus uberis; Virulence
Mesh:
Year: 2022 PMID: 35489013 PMCID: PMC9206625 DOI: 10.1007/s10482-022-01740-w
Source DB: PubMed Journal: Antonie Van Leeuwenhoek ISSN: 0003-6072 Impact factor: 2.158
Assembly statistics of 24 Streptococcus uberis isolates
| Isolate | Sequencing platform | No. of contigs | N50 | Average coverage range |
|---|---|---|---|---|
| Su-1 | Illumina NextSeq 500 | 28 | 159,211 | 275–2463 |
| Su-2 | Illumina MiSeq | 16 | 175,018 | 184–1665 |
| Su-3 | Illumina MiSeq | 15 | 457,442 | 134–1210 |
| Su-4 | Illumina NextSeq 500 | 31 | 197,492 | 83–3848 |
| Su-5 | Illumina MiSeq | 14 | 206,517 | 130–1164 |
| Su-6 | Illumina MiSeq | 24 | 229,596 | 100–932 |
| Su-7 | Illumina NextSeq 500 | 23 | 313,412 | 138–3145 |
| Su-8 | Illumina MiSeq | 37 | 123,181 | 202–3331 |
| Su-9 | Illumina NextSeq 500 | 21 | 255,232 | 129–3911 |
| Su-10 | Illumina NextSeq 500 | 38 | 206,273 | 95–4030 |
| Su-11 | Illumina MiSeq | 13 | 436,510 | 160–1445 |
| Su-12 | Illumina MiSeq | 12 | 204,844 | 166–1565 |
| Su-13 | Illumina MiSeq | 15 | 439,515 | 74–1330 |
| Su-14 | Illumina MiSeq | 12 | 1,031,011 | 92–1363 |
| Su-15 | Illumina MiSeq | 13 | 1,030,881 | 265–3465 |
| Su-16 | Illumina MiSeq | 13 | 1,030,845 | 458–3633 |
| Su-17 | Illumina MiSeq | 12 | 439,836 | 406–4468 |
| Su-18 | Illumina MiSeq | 49 | 79,688 | 56–3424 |
| Su-19 | Illumina MiSeq | 12 | 439,511 | 206–1692 |
| Su-20 | Illumina MiSeq | 18 | 320,790 | 114–2080 |
| Su-21 | Illumina MiSeq | 21 | 187,067 | 83–1150 |
| Su-22 | Illumina MiSeq | 12 | 439,515 | 121–2124 |
| Su-23 | Illumina MiSeq | 13 | 436,512 | 474–4427 |
| Su-24 | Illumina MiSeq | 16 | 439,517 | 352–5571 |
Representative Streptococcus uberis AST phenotype
| Parameter | Interpretation result | MIC values |
|---|---|---|
| Amoxicillin/clavulanic acid | S | < = 4/2 |
| Ampicillin | S | < = 4 |
| Cefquinome | S | < = 1 |
| Cefazolin | S | < = 4 |
| Cefoperazon | S | < = 2 |
| Erythromycin | S | < = 0.125 |
| Kanamycin/cephalexin | S | < = 4/0.4 |
| Marbofloxacin | S | = 0.5 |
| Oxacillin | S | < = 1 |
| Penicilling | S | < = 0.125 |
| Pirlimycin | S | < = 1 |
Sequencing statistics of 24 Streptococcus uberis isolates plus the strains 0140 J and EF20
| Isolate | sequence size (bp) | Number of contigs (> 500 bp) | Longest contig (bp) | Shortest contig (bp) | GC % |
|---|---|---|---|---|---|
| Su-01 | 1,821,188 | 21 | 515,871 | 610 | 36.5 |
| Su-02 | 1,818,057 | 12 | 1,002,414 | 800 | 36.5 |
| Su-03 | 1,883,847 | 8 | 1,008,567 | 933 | 36.4 |
| Su-04 | 1,849,257 | 21 | 318,687 | 933 | 36.5 |
| Su-05 | 1,805,858 | 8 | 1,000,761 | 800 | 36.4 |
| Su-06 | 1,911,851 | 11 | 524,326 | 5 579 | 36.3 |
| Su-07 | 1,950,395 | 14 | 659,959 | 891 | 36.4 |
| Su-08 | 1,949,859 | 18 | 653,595 | 553 | 36.3 |
| Su-09 | 1,950,920 | 9 | 1,070,520 | 933 | 36.4 |
| Su-10 | 1,983,343 | 17 | 429,199 | 606 | 36.4 |
| Su-11 | 1,883,972 | 8 | 1,061,615 | 800 | 36.4 |
| Su-12 | 1,875,458 | 8 | 1,032,662 | 548 | 36.3 |
| Su-13 | 1,875,842 | 8 | 1,032,662 | 933 | 36.3 |
| Su-14 | 1,875,689 | 9 | 1,031,954 | 933 | 36.3 |
| Su-15 | 1,876,200 | 8 | 1,032,186 | 933 | 36.3 |
| Su-16 | 1,876,102 | 11 | 1,031,729 | 508 | 36.3 |
| Su-17 | 1,875,804 | 8 | 1,032,437 | 933 | 36.3 |
| Su-18 | 1,982,968 | 50 | 922,189 | 508 | 36.4 |
| Su-19 | 1,876,339 | 9 | 1,032,186 | 933 | 36.3 |
| Su-20 | 1,896,764 | 15 | 1,035,846 | 567 | 36.4 |
| Su-21 | 1,875,591 | 9 | 690,884 | 933 | 36.3 |
| Su-22 | 1,875,809 | 8 | 1,032,566 | 933 | 36.3 |
| Su-23 | 1,884,146 | 9 | 1,061,387 | 535 | 36.4 |
| Su-24 | 1,876,146 | 8 | 1,032,828 | 933 | 36.3 |
| 0140J | 1,852,352 | 1 | – | – | 36.6 |
| EF20 | 1,932,039 | 17 | 1,013,731 | 366 | 36.3 |
Fig. 1There is a high statistically significant difference (p < 0.01) between groups A and B and between groups B and C. Groups A and C differed significantly (p < 0.05). There is a high statistically signifant difference between all genomes currently found in the NBCI database and the total genome size of group A, B and C combined. Boxplot and calculation was created with R-Studio
Fig. 2Core genome phylogenetic tree. Core genes of these genomes were computed in EDGAR 3.0 based on muscle alignment. An approximately-maximum-likelihood phylogenetic tree was calculated using the FastTree software. The core genome analysis was based on 1567 genes per genome in 24 strains plus the reference strains 0140J and EF20. The core had 489,494 amino acid residues/bp per genome, 12,726,844 in total. Bar, 0.001 nucleotide substitutions per site. The values at the branches are Shimodaira-Hasegawa support values. Isolates are highlighted according to group affiliation (Group A: red; Group B: orange; Group C: blue)
Fig. 3Pan versus core development plot to gain insight into the stability of the pan- and core-genome of the isolates. Results were obtained using EDGAR 3.0. Starting with the first contig, consecutive numbers for the core and pan genome size were calculated and plotted. The plot shows an increase of the pan-genome (black line) and a decrease of the core-genome (grey line) as more genomes are added
Fig. 4Overview of the average nucleotide match between genomes. The isolates were grouped according to their match. Within each box, the identity was given in percent. Darker heat map colours indicate higher relatedness. Results were obtained using EDGAR 3.0 based on a BLASTN comparison of the genome sequences
MLST results for 24 isolates plus the strains 0140J and EF20
| Isolate | Disease status | Allele | ST | CC | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Su-01 | C | 1 | 37 | 4 | 2 | 62 | 1 | 3 | – | |
| Su-02 | C | 1 | 37 | 4 | 2 | 62 | 1 | 3 | – | |
| Su-03 | C | 1 | 1 | 4 | 2 | 1 | 3 | – | ||
| Su-04 | C | 2 | 33 | 4 | 2 | 1 | 3 | – | ||
| Su-05 | C | 1 | 37 | 5 | 2 | 62 | 1 | 3 | – | |
| Su-06 | C | 2 | 1 | 10 | 3 | 2 | 3 | 3 | 931 | – |
| Su-07 | C | 2 | 1 | 5 | 1 | 1 | 3 | 5 | ||
| Su-08 | C | 2 | 1 | 10 | 3 | 2 | 3 | 3 | 931 | – |
| Su-09 | C | 2 | 1 | 5 | 1 | 1 | 3 | 5 | ||
| Su-10 | C | 2 | 1 | 5 | 1 | 1 | 3 | 5 | ||
| Su-11 | C* | 2 | 37 | 5 | 1 | 97 | 1 | 3 | 964 | – |
| Su-12 | C* | 2 | 1 | 65 | 1 | 1 | 3 | 5 | ||
| Su-13 | C* | 2 | 1 | 65 | 1 | 1 | 3 | 5 | ||
| Su-14 | C* | 2 | 1 | 65 | 1 | 1 | 3 | 5 | ||
| Su-15 | C* | 2 | 1 | 65 | 1 | 1 | 3 | 5 | ||
| Su-16 | C* | 2 | 1 | 65 | 1 | 1 | 3 | 5 | ||
| Su-17 | C* | 2 | 1 | 65 | 1 | 1 | 3 | 5 | ||
| Su-18 | C* | 2 | 1 | 65 | 1 | 1 | 3 | 5 | ||
| Su-19 | C* | 2 | 1 | 65 | 1 | 1 | 3 | 5 | ||
| Su-20 | C* | 2 | 1 | 65 | 1 | 1 | 3 | 5 | ||
| Su-21 | C* | 2 | 1 | 65 | 1 | 1 | 3 | 5 | ||
| Su-22 | C* | 2 | 1 | 65 | 1 | 1 | 3 | 5 | ||
| Su-23 | C* | 2 | 37 | 5 | 1 | 97 | 1 | 3 | 964 | – |
| Su-24 | C* | 2 | 1 | 65 | 1 | 1 | 3 | 5 | ||
| 0140J | – | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 5 |
| EF20 | – | 15 | 1 | 4 | 3 | 13 | 4 | 3 | 55 | – |
In bold are the allele variants and resulting STs that were novel in this study. Isolates marked with asterisks (*), showed the particularly severe disease status
Fig. 5All virulence genes that were not found in all isolates with a gene coverage of 100 % are listed. The gene-coverage in percent is indicated in the boxes. The heatmap was created with R-Studio from the results generated with ABRicate
Fig. 6All prophage sequences found are listed. The score (< 70: incomplete; 70–90: questionable; > 90: intact) for each sequence is indicated in the boxes. The heatmap was created with R-Studio from the results generated with PHASTER